Purposely Patient, Llc in Menden, IA - Counselor

Purposely Patient, Llc is a mental health clinic (Counselor - Mental Health) in Menden, Iowa. The current practice location for Purposely Patient, Llc is 100 Pecan Lane Apt 3, Menden, Iowa. For appointments, you can reach them via phone at (402) 403-2800. The mailing address for Purposely Patient, Llc is 5001 Sergeant Rd Ste 50, Sioux City, Iowa and phone number is (402) 403-2800.

Purposely Patient, Llc is licensed to practice in * (Not Available) (license number ) and its NPI number is 1336900844. This medical practice does not participate in medicare program and thus may not accept your medicare insurance. You may check if they accept your insurance at (402) 403-2800.

Contact Information

	Purposely Patient, Llc
	100 Pecan Lane Apt 3 Menden IA 51553
	(402) 403-2800
	Not Available

Mental Health Clinic Profile

Full Name	Purposely Patient, Llc
Speciality	Counselor - Mental Health
Location	100 Pecan Lane Apt 3, Menden, Iowa
Authorized Official Name and Position	Natalie Erdahl (OWNER/PROVIDER)
Authorized Official Contact	4024032800
Accepts Medicare Insurance	This clinic does not participate in Medicare Program.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Purposely Patient, Llc 5001 Sergeant Rd Ste 50 Sioux City IA 51106-4777 Ph: (402) 403-2800	Purposely Patient, Llc 100 Pecan Lane Apt 3 Menden IA 51553 Ph: (402) 403-2800

NPI Details:

NPI Number	1336900844
Provider Enumeration Date	01/22/2024
Last Update Date	01/22/2024
Certification Date	01/15/2024

Medical Identifiers

Medical identifiers for Purposely Patient, Llc such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1336900844	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
101YM0800X	Counselor - Mental Health	(* (Not Available))	Primary

News Archive

Common gene test to predict breast cancer recurrence may not be cost-effective

The most commonly used gene expression profile test used to help predict breast cancer recurrence may not be as cost-effective as once thought, say a team of researchers led by Georgetown Lombardi Comprehensive Cancer Center.

BeiGene collaborates with SpringWorks to evaluate new combinational therapy for solid tumors

BeiGene, Ltd., a commercial-stage biopharmaceutical company focused on developing and commercializing innovative molecularly-targeted and immuno-oncology drugs for the treatment of cancer, and SpringWorks Therapeutics, a clinical-stage rare disease and oncology company focused on sourcing and developing innovative treatments for underserved patient populations, announced today that the companies have entered into a global clinical collaboration agreement to evaluate the safety, tolerability and preliminary efficacy of combining BeiGene's investigational RAF dimer inhibitor, lifirafenib and SpringWorks Therapeutics' investigational MEK inhibitor, PD-0325901, in patients with advanced solid tumors.

Living in disadvantaged neighborhoods has direct impact on cellular health

Regardless of chronological age, people who live in neighborhoods with high crime, noise and vandalism are biologically more than a decade older than those who do not, according to a study led by researchers from the University of Pittsburgh.

Study finds prevalence of depression and anxiety in individuals with epilepsy

An analysis of published studies found that in individuals with epilepsy, there is a 20.2% prevalence of anxiety disorders and a 22.9% prevalence of depression. Investigators also found no differences in the prevalence of either depression or anxiety based on the severity of illness.

Researchers investigate whether Zika reservoirs are found in the Americas

Most emerging infectious diseases affecting people are zoonotic - they make the jump from other animals to humans.

Purposely Patient, Llc - Mental Health Clinic in Menden, IA